{"id":"https://openalex.org/W4393092285","doi":"https://doi.org/10.1158/1538-7445.am2024-1657","title":"Abstract 1657: Microfluidics-based screening platform identifies a novel therapeutic approach to targeting EML4-ALK driven cancers","display_name":"Abstract 1657: Microfluidics-based screening platform identifies a novel therapeutic approach to targeting EML4-ALK driven cancers","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393092285","doi":"https://doi.org/10.1158/1538-7445.am2024-1657"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-1657","doi":"https://doi.org/10.1158/1538-7445.am2024-1657","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-1657","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079460736","display_name":"Richard C. Centore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard C. Centore","raw_affiliation_strings":["1Transition Bio, Inc., Watertown, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transition Bio, Inc., Watertown, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew Watson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Watson","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013871638","display_name":"Julia K. Doh","orcid":"https://orcid.org/0000-0001-9375-6947","observed_orcids":["https://orcid.org/0000-0001-9375-6947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia Doh","raw_affiliation_strings":["1Transition Bio, Inc., Watertown, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transition Bio, Inc., Watertown, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094223182","display_name":"Jerome Cattin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerome Cattin","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087727100","display_name":"Cinzia Sgambato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cinzia Sgambato","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078822637","display_name":"Amal Alex","orcid":"https://orcid.org/0000-0001-9801-1274","observed_orcids":["https://orcid.org/0000-0001-9801-1274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amal Alex","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033231138","display_name":"Janhavi Sawant","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janhavi Sawant","raw_affiliation_strings":["1Transition Bio, Inc., Watertown, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transition Bio, Inc., Watertown, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065244224","display_name":"Prathima Radhakrishnan","orcid":"https://orcid.org/0000-0002-1990-0063","observed_orcids":["https://orcid.org/0000-0002-1990-0063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prathima Radhakrishnan","raw_affiliation_strings":["1Transition Bio, Inc., Watertown, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transition Bio, Inc., Watertown, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063442527","display_name":"Jasmine Cornish","orcid":"https://orcid.org/0000-0003-3528-2143","observed_orcids":["https://orcid.org/0000-0003-3528-2143"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jasmine Cornish","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113150029","display_name":"Alex Howarth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Howarth","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006084918","display_name":"Nagakumar Bharatham","orcid":"https://orcid.org/0000-0003-4904-7726","observed_orcids":["https://orcid.org/0000-0003-4904-7726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nagakumar Bharatham","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048226666","display_name":"William E. Arter","orcid":"https://orcid.org/0000-0002-3615-1885","observed_orcids":["https://orcid.org/0000-0002-3615-1885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William E. Arter","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058191684","display_name":"Seema Qamar","orcid":"https://orcid.org/0000-0003-1189-206X","observed_orcids":["https://orcid.org/0000-0003-1189-206X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seema Qamar","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045077852","display_name":"Kadi Liis Saar","orcid":"https://orcid.org/0000-0002-5926-3628","observed_orcids":["https://orcid.org/0000-0002-5926-3628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kadi L. Saar","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061947985","display_name":"Douglas S. Williamson","orcid":"https://orcid.org/0000-0002-5094-5200","observed_orcids":["https://orcid.org/0000-0002-5094-5200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas Williamson","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054110838","display_name":"Andrew Seeber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Seeber","raw_affiliation_strings":["1Transition Bio, Inc., Watertown, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transition Bio, Inc., Watertown, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114138828","display_name":"Neils Groenewegen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neils Groenewegen","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031836910","display_name":"Magdalena A. Czekalska","orcid":"https://orcid.org/0000-0002-4494-4463","observed_orcids":["https://orcid.org/0000-0002-4494-4463"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magdalena Czekalska","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047487360","display_name":"Tadas Kartanas","orcid":"https://orcid.org/0000-0002-1255-4807","observed_orcids":["https://orcid.org/0000-0002-1255-4807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tadas Kartanas","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082654795","display_name":"Niklas Ermann","orcid":"https://orcid.org/0000-0003-0280-8866","observed_orcids":["https://orcid.org/0000-0003-0280-8866"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Niklas Ermann","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ahmed Taher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed Taher","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041530719","display_name":"Tuomas P. J. Knowles","orcid":"https://orcid.org/0000-0002-7879-0140","observed_orcids":["https://orcid.org/0000-0002-7879-0140","https://orcid.org/0000-0002-0016-3008"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tuomas Knowles","raw_affiliation_strings":["2Transition Bio, Inc., Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Transition Bio, Inc., Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087252132","display_name":"Shilpi Arora","orcid":"https://orcid.org/0000-0002-8918-6061","observed_orcids":["https://orcid.org/0000-0002-8918-6061","https://orcid.org/0000-0001-5133-3612"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shilpi Arora","raw_affiliation_strings":["1Transition Bio, Inc., Watertown, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Transition Bio, Inc., Watertown, MA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"1657","last_page":"1657"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eml4-alk-fusion","display_name":"EML4-ALK fusion","score":0.890999972820282},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9179999828338623},{"id":"https://openalex.org/keywords/biomolecular-condensates","display_name":"biomolecular condensates","score":0.8370000123977661},{"id":"https://openalex.org/keywords/phase-separation","display_name":"phase separation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.9359999895095825},{"id":"https://openalex.org/keywords/small-molecule-modulators","display_name":"small molecule modulators","score":0.8579999804496765},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.4950000047683716},{"id":"https://openalex.org/keywords/cancer-therapeutics","display_name":"cancer therapeutics","score":0.47999998927116394},{"id":"https://openalex.org/keywords/liquid-liquid-phase-separation","display_name":"liquid-liquid phase separation","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5116119980812073},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4387966990470886},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37847569584846497},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.36880189180374146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2964388132095337},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27321672439575195}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-1657","doi":"https://doi.org/10.1158/1538-7445.am2024-1657","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-1657","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282981357","https://openalex.org/W4393090887","https://openalex.org/W4385554444","https://openalex.org/W3162519646","https://openalex.org/W2236017705","https://openalex.org/W4401527030","https://openalex.org/W3205549139","https://openalex.org/W6889136093","https://openalex.org/W1897972509","https://openalex.org/W1997476230"],"abstract_inverted_index":{"Abstract":[0],"To":[1],"achieve":[2],"proliferative":[3,156],"dysregulation,":[4],"a":[5,12,51,101,108,135,203,216,249,379],"hallmark":[6],"of":[7,14,24,44,53,63,71,75,97,100,169,178,230,255,271,274,284,287,304,391],"cancer,":[8],"tumor":[9],"cells":[10,32,247],"utilize":[11],"variety":[13],"mechanisms":[15],"to":[16,127,147,185,208,226,316,383],"maintain":[17],"constitutive":[18,163],"oncogenic":[19,117],"signaling":[20,165,293],"in":[21,31,41,191,243,246,261,294],"the":[22,34,60,64,72,76,89,122,158,167,176,272,281,302,392],"absence":[23],"extracellular":[25,155],"cues.":[26],"One":[27],"such":[28],"mechanism":[29,273],"occurs":[30],"expressing":[33],"EML4-ALK":[35,106,123,159,231,241,385],"fusion":[36,86,124,160],"protein.":[37],"This":[38],"fusion,":[39],"found":[40],"about":[42],"4%":[43],"non-small":[45],"cell":[46,192],"lung":[47],"cancer":[48,295],"(NSCLC),":[49],"is":[50,107],"result":[52,177],"an":[54],"inversion":[55],"within":[56,280],"chromosome":[57],"2,":[58],"placing":[59],"3\u2019":[61],"end":[62,74],"ALK":[65,103,128,164,257,292],"(anaplastic":[66],"lymphoma":[67],"kinase)":[68],"gene":[69],"downstream":[70],"5\u2019":[73],"EML4":[77,98,288],"(echinoderm":[78],"microtubule":[79],"associated":[80],"protein-like":[81],"4)":[82],"gene.":[83],"The":[84],"resulting":[85],"protein":[87,161],"contains":[88],"oligomerization":[90],"domain":[91],"and":[92,181,193,245,290],"additional":[93],"disordered":[94,282],"sequence":[95],"elements":[96],"upstream":[99],"functional":[102],"kinase":[104,130],"domain.":[105],"critical":[109],"driver":[110],"for":[111,188,395],"these":[112],"tumors,":[113],"promoting":[114],"aberrant":[115],"ALK-dependent":[116],"signaling.":[118],"While":[119],"tumors":[120],"harboring":[121],"initially":[125],"respond":[126],"tyrosine":[129],"inhibitors":[131],"(TKIs),":[132],"resistance":[133],"remains":[134],"significant":[136],"clinical":[137],"challenge":[138],"requiring":[139],"new":[140],"therapeutic":[141,381],"approaches.":[142],"Recently,":[143],"it":[144],"has":[145],"come":[146],"be":[148,186],"understood":[149],"that":[150,239,254,310],"rather":[151],"than":[152],"responding":[153],"through":[154,166,248],"cues,":[157],"elicits":[162],"formation":[168],"cytoplasmic":[170],"biomolecular":[171],"condensates.":[172,232],"These":[173],"condensates":[174,242],"are":[175],"phase":[179],"separation":[180],"have":[182,214,312],"been":[183,314],"shown":[184],"causal":[187],"disease":[189],"phenotypes":[190],"animal":[194],"models":[195],"driven":[196,386],"by":[197,206],"EML4-ALK,":[198],"establishing":[199],"condensate":[200],"modulation":[201],"as":[202,264,266],"novel":[204,217,250,380],"means":[205],"which":[207],"treat":[209],"TKI-resistant":[210,263],"tumors.":[211,268],"Here,":[212],"we":[213,236],"developed":[215],"proprietary":[218],"microfluidics-based":[219],"high":[220],"throughput":[221],"screening":[222,376],"platform":[223,377],"(termed":[224],"PhaseScanTM)":[225],"identify":[227,317],"small-molecule":[228],"modulators":[229],"Using":[233],"this":[234],"technology,":[235],"identified":[237],"compounds":[238],"disrupt":[240],"vitro":[244],"mechanism,":[251],"distinct":[252],"from":[253],"known":[256],"TKIs,":[258],"providing":[259],"utility":[260],"both":[262],"well":[265],"TKI-na\u00efve":[267],"Further":[269],"profiling":[270],"action":[275],"(MoA)":[276],"revealed":[277],"specific":[278],"modification":[279],"region":[283],"EML4,":[285],"disruption":[286],"oligomerization,":[289],"defective":[291],"cells.":[296],"Thus,":[297],"our":[298],"PhaseScanTM":[299],"methodology":[300],"enabled":[301],"identification":[303,322],"novel,":[305],"functionally":[306],"active":[307],"chemical":[308],"matter":[309],"would":[311],"otherwise":[313],"challenging":[315],"utilizing":[318],"any":[319],"conventional":[320],"hit":[321],"methodology.":[323],"Citation":[324],"Format:":[325],"Richard":[326],"C.":[327],"Centore,":[328],"Matthew":[329],"Watson,":[330],"Julia":[331],"Doh,":[332],"Jerome":[333],"Cattin,":[334],"Cinzia":[335],"Sgambato,":[336],"Amal":[337],"Alex,":[338],"Janhavi":[339],"Sawant,":[340],"Prathima":[341],"Radhakrishnan,":[342],"Jasmine":[343],"Cornish,":[344],"Alex":[345],"Howarth,":[346],"Nagakumar":[347],"Bharatham,":[348],"William":[349],"E.":[350],"Arter,":[351],"Seema":[352],"Qamar,":[353],"Kadi":[354],"L.":[355],"Saar,":[356],"Douglas":[357],"Williamson,":[358],"Andrew":[359],"Seeber,":[360],"Neils":[361],"Groenewegen,":[362],"Magdalena":[363],"Czekalska,":[364],"Tadas":[365],"Kartanas,":[366],"Niklas":[367],"Ermann,":[368],"Ahmed":[369],"Taher,":[370],"Tuomas":[371],"Knowles,":[372],"Shilpi":[373],"Arora.":[374],"Microfluidics-based":[375],"identifies":[378],"approach":[382],"targeting":[384],"cancers":[387],"[abstract].":[388],"In:":[389],"Proceedings":[390],"American":[393],"Association":[394],"Cancer":[396,414],"Research":[397],"Annual":[398],"Meeting":[399],"2024;":[400],"Part":[401],"1":[402],"(Regular":[403],"Abstracts);":[404],"2024":[405],"Apr":[406],"5-10;":[407],"San":[408],"Diego,":[409],"CA.":[410],"Philadelphia":[411],"(PA):":[412],"AACR;":[413],"Res":[415],"2024;84(6_Suppl):Abstract":[416],"nr":[417],"1657.":[418]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2024-03-23T00:00:00"}